SecurityDWCH / Datawatch Corp. (237917208)
President & CEOMorrison Michael Anthony
IndustryPrepackaged Software
Institutional Owners51
Institutional Shares6,047,330 - 47.49%
Common Shares Outstanding12,733,081 shares (as of 2018-06-30)
Institutional Value$ 46,174,000 USD

Institutional Stock Ownership and Shareholders

DWCH / Datawatch Corp. Institutional Ownership

Datawatch Corp. (NASDAQ:DWCH) has 51 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,047,330 shares. Largest shareholders include Renaissance Technologies LLC, Division of Investment, Department of the Treasury, State of New Jersey, Vanguard Group Inc, ACK Asset Management LLC, G2 Investment Partners Management LLC, BlackRock Inc., BlackRock Institutional Trust Company, N.A., State of New Jersey Common Pension Fund D, Wasatch Advisors Inc, and Essex Investment Management Co Llc.
Datawatch Corp. (NASDAQ:DWCH) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR JP Morgan Chase & Co 6,423 10,540 64.10 56 100 78.57
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 69,676 69,222 -0.65 601 657 9.32
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 0 270 0 3
2018-08-14 13F-HR DEUTSCHE BANK AG\ 162,537 126,431 -22.21 1,405 1,201 -14.52
2018-07-17 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 184,826 185,049 0.12 1,599 1,758 9.94
2018-07-30 13F-HR SIMPLEX TRADING, LLC Put 1 0 -100.00 0 0
2018-08-09 13F-HR THOMPSON SIEGEL & WALMSLEY LLC 8,700 0 -100.00 75 0 -100.00
2018-08-14 13F-HR Invesco Ltd. 16,250 15,166 -6.67 141 144 2.13
2018-08-09 13F-HR Royce & Associates LLC 55,977 39,587 -29.28 484 376 -22.31
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 79,443 77,543 -2.39 687 737 7.28
2018-08-01 13F-HR TrueNorth, Inc. 1,106 11
2018-08-01 13F-HR Connor, Clark & Lunn Investment Management Ltd. 10,427 0 -100.00 90 0 -100.00
2018-08-14 13F-HR PANAGORA ASSET MANAGEMENT INC 6,160 6,160 0.00 53 59 11.32
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 64,643 64,643 0.00 559 614 9.84
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 0 34,384 0 327
2018-08-14 13F-HR MACQUARIE GROUP LTD 22,389 0 -100.00 194 0 -100.00
2018-08-08 13F-HR Russell Investments Group, Ltd. 0 17,200 0 163
2018-08-01 13F-HR ALGERT GLOBAL LLC 100,815 82,989 -17.68 872 788 -9.63
2017-02-10 13F-HR BlackRock Investment Management, LLC 1,775 1,775 0.00 13 10 -23.08
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 299,710 299,710 0.00 2,221 1,648 -25.80
2018-08-10 13F-HR Teton Advisors, Inc. 23,000 23,000 0.00 199 219 10.05
2018-07-31 13F-HR RAY GERALD L & ASSOCIATES LTD 58,426 0 -100.00 675 0 -100.00
2018-08-14 13F-HR OBERWEIS ASSET MANAGEMENT INC/ 150,998 150,998 0.00 1,306 1,434 9.80
2018-08-09 13F-HR BlackRock Inc. 310,554 314,509 1.27 2,686 2,988 11.24
2018-08-14 13F-HR MENTA CAPITAL LLC 10,700 102
2018-07-30 13F-HR State of New Jersey Common Pension Fund D 280,000 270,000 -3.57 2,422 2,565 5.90
2018-08-14 13F-HR STATE STREET CORP 10,000 95
2018-08-14 13F-HR VIEX Capital Advisors, LLC 165,327 0 -100.00 1,430 0 -100.00
2018-08-02 13F-HR WASATCH ADVISORS INC 240,973 2,289
2018-08-14 13F-HR PDT Partners, LLC 22,900 22,900 0.00 198 218 10.10
2018-08-10 13F-HR Cutler Group LP 2,331 2,231 -4.29 20 21 5.00
2018-08-13 13F-HR Allianz Asset Management AG 276,135 108,698 -60.64 2,389 1,033 -56.76
2017-11-09 13F-HR TFS CAPITAL LLC 11,673 0 -100.00 109 0 -100.00
2018-08-09 13F-HR Mutual of America Capital Management LLC 5,000 0 -100.00 43 0 -100.00
2018-08-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 13,866 0 -100.00 120 0 -100.00
2018-07-31 13F-HR Concourse Capital Management, LLC 38,897 38,897 0.00 336 370 10.12
2018-07-30 13F-HR SIMPLEX TRADING, LLC 17 0 -100.00 0 0
2018-08-14 13F-HR MORGAN STANLEY 25,967 0 -100.00 225 0 -100.00
2018-08-14 13F-HR UBS Group AG 1,558 1,518 -2.57 14 14 0.00
2018-08-14 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 40,776 46,676 14.47 353 443 25.50
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 17,077 12,267 -28.17 148 117 -20.95
2017-10-26 13F-HR Acrospire Investment Management LLC 643 0 -100.00 6 0 -100.00
2018-08-13 13F-HR OXFORD ASSET MANAGEMENT 118,075 101,235 -14.26 1,021 960 -5.97
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 100 100 0.00 1 1 0.00
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 663 663 0.00 6 6 0.00
2018-08-14 13F-HR Alambic Investment Management, L.P. 130,841 0 -100.00 1,132 0 -100.00
2018-08-09 13F-HR GSA CAPITAL PARTNERS LLP 20,200 0 -100.00 175 0 -100.00
2018-08-14 13F-HR S Squared Technology, LLC 137,269 147,269 7.28 1,187 1,399 17.86
2018-08-13 13F-HR Renaissance Technologies LLC 965,200 8,349
2018-08-08 13F-HR Spark Investment Management LLC 31,700 10,700 -66.25 274 101 -63.14
2018-08-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 5,300 50
2018-07-24 13F-HR Trellus Management Company, LLC 23,900 0 -100.00 207 0 -100.00
2018-08-15 13F-HR/A PUTNAM INVESTMENTS LLC 108,178 108,178 0.00 936 1,028 9.83
2018-08-07 13F-HR Trexquant Investment LP 23,539 0 -100.00 204 0 -100.00
2018-08-13 13F-HR ACK Asset Management LLC 435,000 4,151
2018-08-14 13F-HR QS Investors, LLC 640 640 0.00 6 6 0.00
2018-07-27 13F-HR Wealthstreet Investment Advisors, Llc 58,426 58,426 0.00 505 555 9.90
2018-07-24 13F-HR ACADIAN ASSET MANAGEMENT LLC 32,445 1,261 -96.11 282 12 -95.74
2018-08-14 13F-HR VANGUARD GROUP INC 439,177 448,485 2.12 3,799 4,261 12.16
2018-09-18 13F-HR/A NORTHERN TRUST CORP 32,561 32,661 0.31 282 311 10.28
2017-01-10 SC 13G Division of Investment, Department of the Treasury, State of New Jersey 1,018,000 962,000 -5.50
2017-02-10 13F-HR BlackRock Fund Advisors 24,805 32,243 29.99 184 177 -3.80
2018-08-09 13F-HR Gradient Investments LLC 85,600 813
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 9,431 10,039 6.45 82 96 17.07
2018-08-10 13F-HR Cutler Group LP Put 1,000 1,000 0.00 2 1 -50.00
2018-07-24 13F-HR HARVEST MANAGEMENT LLC 10,000 10,000 0.00 87 95 9.20
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 59,193 0 -100.00 512 0 -100.00
2018-08-14 13F-HR G2 Investment Partners Management LLC 391,415 329,058 -15.93 3,386 3,126 -7.68
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 17,110 18,130 5.96 148 173 16.89

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

18h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

18h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

20h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Datawatch Stays On Its Bumpy Track

2018-08-21 seekingalpha
But the gains have been choppy, and the ride somewhat nerve-wracking, given concerns about competition and profitability.

18 High-Growth Stocks With Massive Upside Ahead

2018-08-15 investorplace
This has been a market that favors high-growth stocks and not value plays. Obviously, the rising tide of the nine-year-plus bull market has lifted value boats as well. But clearly, the market of late has prioritized revenue growth over profit growth, to the point that many longtime value investors are in something close to despair. (108-8)

Datawatch: Potential Turnaround In The Works

2018-07-19 seekingalpha
Datawatch reported favorable Q3 earnings results after heavily disappointing analysts in last quarter's results. Revenues grew more than 40% this quarter, after just 7% growth in Q2.

Datawatch Corporation (DWCH) CEO Michael Morrison on Q3 2018 Results - Earnings Call Transcript

2018-07-19 seekingalpha
Greetings and welcome to the Datawatch Corporation Third Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

Datawatch: How Much Longer Do We Keep Waiting?

2018-04-30 seekingalpha
Datawatch, the data analytics company that competes with Alteryx, posted anemic growth in Q2 despite folding in the results of a recently acquired company, Angoss Software. (1-1)

CUSIP: 237917208